Cerebroprotective effect of isolated harmine alkaloids extracts of seeds of Peganum harmala L. on Sodium nitrite-induced hypoxia and ethanol-induced neurodegeneration in young mice

Pakistan Journal of Biological Sciences

Volumn 16, Issue 23, 2013, Pages 1687-1697

  Biradar, S M ^a   Joshi, Hanumanthachar ^b   Tarak, K C ^c  

^a BLDE University Campus   (India)

^b Sarada Vilas College of Pharmacy   (India)

^c S E T S COLLEGE OF PHARMACY   (India)

Author keywords

AchE; Cerebroprotective; Harmine alkaloids; MAO A; Peganum harmala

Indexed keywords

ACETYLCHOLINESTERASE; ACHE PROTEIN, MOUSE; ALCOHOL; AMINE OXIDASE (FLAVIN CONTAINING); GLUTATHIONE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HARMINE; NEUROPROTECTIVE AGENT; PLANT EXTRACT; SODIUM NITRITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL; ANIMAL BEHAVIOR; APOPTOSIS; ARTICLE; BRAIN; BRAIN HYPOXIA; CELL PROTECTION; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COGNITION; COGNITIVE DEFECT; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; ISOLATION AND PURIFICATION; MALE; MEDICINAL PLANT; METABOLISM; MOTOR ACTIVITY; MOUSE; NERVE DEGENERATION; PATHOLOGY; PEGANUM; PHYTOTHERAPY; PLANT SEED; PSYCHOLOGICAL ASPECT; REACTION TIME; TIME;

ACETYLCHOLINESTERASE; ANIMALS; APOPTOSIS; BEHAVIOR, ANIMAL; BRAIN; COGNITION; COGNITION DISORDERS; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; GLUTATHIONE; GPI-LINKED PROTEINS; HARMINE; HYPOXIA, BRAIN; MALE; MICE; MONOAMINE OXIDASE; MOTOR ACTIVITY; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; PEGANUM; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; REACTION TIME; SEEDS; SODIUM NITRITE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

EID: 84877881562     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2013.1687.1697     Document Type: Article

References (42)

1. ADI, 2010. World Alzheimer report 2010: The global economic impact of dementia. Alzheimer's Disease International, London. http://aarpintorg.stage.bridgelinedigital.net:8020/resources/resources_show.htm?doc_id=1392905.
2. Babar, M.K. and Z. Qureshi, 1995. A study of effects of harmidine on C.N.S. of animals. Pakistan J. Pharm. Sci., 8: 23-37.
3. Behl, C., 1999. Alzheimer's disease and oxidative stress: Implications for novel therapeutic approaches. Prog. Neurobiol., 57: 301-323.
4. Blazer, D.G., C.F. Federspiel, W.A. Ray and W. Schaffner, 1983. The risk of anticholinergic toxicity in the elderly: A study of prescribing practices in two populations. J. Gerontol., 38: 31-35.
5. Bullock, R., 2004. Future directions in the treatment of Alzheimer's disease. Expert Opin. Invest. Drugs, 13: 303-314.
6. Burns, A. and J. O'Brien, 2006. Clinical practice with anti-dementia drugs: A consensus statement from British association for psychopharmacology. J. Psychopharmacol., 20: 732-755.
7. Collins, R.J., B.V. Harmon, G.C. Gobe and J.F. Kerr, 1992. Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int. J. Radiat. Biol., 61: 451-453.
8. Cumin, R., E.F. Bandle, E. Gamzu and W.E. Haefely, 1982. Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents. Psychopharmacolology, 78: 104-111.
9. Devi, P.B. and R. Ramasubramaniaraja, 2009. Dental caries and medicinal plants-an overview. J. Pharm. Res., 2: 1669-1675.
10. Dhwaj, A.V. and R. Singh, 2011. Reversal effect of Asparagus racemosus Wild (Liliaceae) root extract on memory deficits of mice. Int. J. Drug Dev. Res., 3: 314-323.
11. Ellerby, H.M., S.J. Martin, L.M. Ellerby, S.S. Naiem and S. Rabizadeh et al., 1997. Establishment of a cell-free system of neuronal apoptosis: Comparison of premitochondrial, mitochondrial and postmitochondrial phases. J. Neurosci., 17: 6165-6178.
12. Farzin, D. and N. Mansouri, 2006. Antidepressant-like effect of harmane and other β-carbolines in the mouse forced swim test. Eur. Neuropsychopharmacol., 16: 324-328.
13. Gibson, G.E. and T.E. Duffy, 1981. Impaired synthesis of acetylcholine by mild hypoxic hypoxia or nitrousoxide. J. Neurochem., 36: 28-33.
14. Gibson, G.E., W. Pulsinelli, J.P. Blass and T.E. Duffy, 1981. Brain dysfunction in mild to moderate hypoxia. Am. J. Med., 70: 1247-1254.
15. Guacobini, E., 1990. Cholinergic system in Alzheimer's disease. Prog. Brain Res., 84: 321-334.
16. Hanumanthacahar, J. and P. Milind, 2005. Effects of piperine on memory and behavior mediated via monoamine neurotransmitters. J. Tradit. Med., 22: 39-43.
17. Jain, N.N., C.C. Ohal, S.K. Shroff, R.H. Bhutada, R.S. Somani, V.S. Kasture and S.B. Kasture, 2003. Clitoria ternatea and the CNS. Pharmacol. Biochem. Behav., 75: 529-536.
18. Joshi, H. and M. Parle, 2006. Nardostachys jatamansi improves learning and memory in mice. J. Med. Food, 9: 113-118.
19. Martinez, J.L., R.A. Jensen, B. J. Vasquez, J.S. Lacob, J.L. McGaugh and R.E. Purdy, 1979. Acqisition deficits induced by sodiumnitrite in rats and mice. Pschychopharmacology, 60: 221-228.
20. Monsef, H.R., A. Ghobadi, M. Iranshahi and M. Abdollahi, 2004. Antinociceptive effects of Peganum harmala L. alkaloid extract on mouse formalin test. J. Pharm. Pharm. Sci., 7: 65-69.
21. Moron, M.S., J. Depierre and B. Mannervik, 1979. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochem. Biophys. Acta, 582: 67-78.
22. Murchison, C.F., X.Y. Zhang, W.P. Zhang, M. Ouyang, A. Lee and S.A. Thomas, 2004. A distinct role for Norepinephrine in memory retrieval. Cell, 117: 131-143.
23. Nordberg, A. and A.L. Svensson, 1998. Cholinesterase inhibitors in the treatment of Alzheimer's disease: A comparison of tolerability and pharmacology. Drug Safety, 19: 465-480.
24. Parle, M. and N. Singh, 2004. Animal models for testing memory. Asia Pac. J. Pharmacol., 16: 101-120.
25. Pratico, D., 2008. Oxidative stress hypothesis in Alzheimer's disease: A reappraisal. Trends Pharmacol. Sci., 29: 609-615.
26. Pulera, M.R., L.M. Adams, H. Liu, D.G. Santos and R.N. Nishimura et al., 1998. Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia. Stroke, 29: 2622-2630.
27. Rogers, S.H., M.R. Farlow, R.S. Doody, R. Mohs and L.I. Friedhoff, 1998. A 24-week, double blind, placebocontrolledtrial of donepezil in patient's withAlzheimer's disease. Neurology, 50: 136-145.
28. Sastry, J.L.N., 2007. Madhava Nidanam (Roga Viniscaya) of Madhavakara (A Treatise on Ayurveda). Chaukhambha Orientalia Varanasi, USA., Pages: 278.
29. Schauwecker, P.E. and O. Steward, 1997. Genetic determinants of susceptibility to excitotoxic cell death: Implications for gene targeting approaches. Proc. Natl. Acad. Sci. USA., 94: 4103-4108.
30. Scheuer, K., A. Rostock, R. Bartsch and W.E. Muller, 1999. Piracetam improves cognitive performance by restoring neurochemical deficits of the aged rat brain. Pharmacopsychiatry, 32: 10-16.
31. Schindler, U., D.K. Rush and S. Fielding, 1994. Nootropic drugs: Animal models for studying effects on cognition. Drug Dev. Res., 4: 567-576.
32. Silversa, J.M., S. Tokunagaa, R.B. Berrya, A.M. Whiteb and D.B. Matthewsa, 2003. Impairments in spatial learning and memory: Ethanol, allopregnanolone and the hippocampus. Brain Res. Rev., 43: 275-284.
33. Slater, T.F. and B.C. Sawyer, 1971. The stimulatory effects of carbon tetrachloride and other halogenoalkanes or peroxidative reactions in rat liver fractions in vitro. General features of the systems used. Biochem. J., 123: 805-814.
34. Srikumar, B.N., K. Ramkumar, T.R. Raju and B.S. Shankaranarayana Rao, 2004. Assay of Acetylcholinesterase Activity in the Brain. In: Brain and Behavior, Raju, T.R., B.M. Kutty, T.N. Sathyaprabha and B.S. Shanakranarayana Rao (Eds.). National Institute of Mental Health and Neurosciences, Bangalore, India, pp: 142-144.
35. Srinivasan, V., 2002. Melatonin oxidative stress and neurodegenerative diseases. Ind. J. Exp. Biol., 40: 668-679.
36. Tse, S.Y.H., I.T. Mak and B.F. Dickens, 1991. Antioxidative properties of harmane and β-carboline alkaloids. Biochem. Pharmacol., 42: 459-464.
37. Turner, R.A., 1972. Screening Procedure in Pharmacology. Vol. 1, 1st Edn., Academic Press, Noida, India.
38. Vasudevan, M. and M. Parle, 2006. Pharmacological action of Thespesia populnea relevant to Alzheimer's disease. Phytomedicine, 13: 677-687.
39. Wimo, A., B. Winblad and L. Jonsson, 2010. The worldwide societal costs of dementia: Estimates for 2009. Alzheimers Dementia, 6: 98-103.
40. Yoganarasimhan, S.N., 1996. Medicinal Plants of India: Karnataka. Vol. 1, Interline Publishing, India, ISBN: 9788172960568, Pages: 237.
41. Yousuf, S., S. Salim, M. Ahmad, A.S. Ahmed, M.A. Ansari and F. Islam, 2005. Protective effect of Khamira Abresham Uood Mastagiwala against free radical induced damage in focal cerebral ischemia. J. Ethnopharmacol., 99: 179-184.
42. Zhou, R., J. Wang, S. Li and Y. Liu, 2009. Supercritical fluid extraction of monoamine oxidase inhibitor from antler velvet. Sep. Purif. Technol., 65: 275-281.